Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leigh Perreault

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
The New England Journal of Medicine|November 13, 2024
Tirzepatide for Obesity Treatment and Diabetes PreventionAnia M Jastreboff, Carel W le Roux, Adam Stefanski, et al.
Diabetes|March 8, 2011
Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention programMarie-France Hivert, Kathleen A Jablonski, Leigh Perreault, et al.
Diabetes Care|October 13, 2017
Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose RegulationWilliam H Herman, Qing Pan, Sharon L Edelstein, et al.
Diabetologia|August 4, 2017
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes StudyVanita R Aroda, William C Knowler, Jill P Crandall, et al.
Diabetes|November 4, 2015
Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program ParticipantsMarie-France Hivert, Costas A Christophi, Paul W Franks, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 9, 2019
Intermuscular adipose tissue directly modulates skeletal muscle insulin sensitivity in humansStephan Sachs, Simona Zarini, Darcy E Kahn, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2021
Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome StudyRonald B Goldberg, Mark T Tripputi, Edward J Boyko, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 6, 2017
Intramuscular triglyceride synthesis: importance in muscle lipid partitioning in humansBryan C Bergman, Leigh Perreault, Allison Strauss, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 30, 2020
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney FoundationKatherine R Tuttle, Frank C Brosius, Matthew A Cavender, et al.
Diabetes|October 5, 2019
Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention ProgramZsu-Zsu Chen, Jinxi Liu, Jordan Morningstar, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
The New England Journal of Medicine|November 13, 2024
Tirzepatide for Obesity Treatment and Diabetes PreventionAnia M Jastreboff, Carel W le Roux, Adam Stefanski, et al.
Diabetes|March 8, 2011
Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention programMarie-France Hivert, Kathleen A Jablonski, Leigh Perreault, et al.
Diabetes Care|October 13, 2017
Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose RegulationWilliam H Herman, Qing Pan, Sharon L Edelstein, et al.
Diabetologia|August 4, 2017
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes StudyVanita R Aroda, William C Knowler, Jill P Crandall, et al.
Diabetes|November 4, 2015
Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program ParticipantsMarie-France Hivert, Costas A Christophi, Paul W Franks, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 9, 2019
Intermuscular adipose tissue directly modulates skeletal muscle insulin sensitivity in humansStephan Sachs, Simona Zarini, Darcy E Kahn, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2021
Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome StudyRonald B Goldberg, Mark T Tripputi, Edward J Boyko, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 6, 2017
Intramuscular triglyceride synthesis: importance in muscle lipid partitioning in humansBryan C Bergman, Leigh Perreault, Allison Strauss, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 30, 2020
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney FoundationKatherine R Tuttle, Frank C Brosius, Matthew A Cavender, et al.
Diabetes|October 5, 2019
Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention ProgramZsu-Zsu Chen, Jinxi Liu, Jordan Morningstar, et al.
Pageof 10